PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver cirrhosis |
| Symptom | |hepatocellular carcinoma |
| Sentences | 74 |
| PubMedID- 20736226 | Left atrial metastasis from hepatocellular carcinoma with liver cirrhosis. |
| PubMedID- 25436303 | As hepatocellular carcinoma is often associated with liver cirrhosis, patients are at risk for postoperative liver failure. |
| PubMedID- 26203823 | An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis. |
| PubMedID- 23958083 | Background & aims: liver transplantation (lt) is a promising treatment for patients with liver cirrhosis associated with hepatocellular carcinoma (hcc). |
| PubMedID- 23732780 | Influence of etiology on host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma receiving intra-arterial chemotherapy. |
| PubMedID- 22504244 | We describe a well-differentiated hepatocellular carcinoma (hcc) with alcohol-related liver cirrhosis in a 69-year-old man. |
| PubMedID- 21695929 | Its efficacy was shown in the sharp study that enabled licensing of sorafenib for the therapy of inoperable, metastasizing hepatocellular carcinoma, including patients with liver cirrhosis, functional class child-pugh a or b, in more than 60 countries worldwide, including the czech republic. |
| PubMedID- 21318009 | Moreover, chronic alcohol consumption is an established risk factor for the development of hepatocellular carcinoma in patients with liver cirrhosis . |
| PubMedID- 23372775 | In china, approximately 40 million people are infected with hcv 5, and it is estimated that 50% to 85% of all individuals infected with hcv develop chronic hepatitis; of these patients, 20% to 30% progress to liver cirrhosis that may lead to hepatocellular carcinoma (hcc). |
| PubMedID- 24760057 | Conclusions: considering the existence of alterations in the metabolism of nutrients in liver cirrhosis patients with and without hepatocellular carcinoma, and also that conventional nutritional assessment methods present limitations for this population, the biochemical laboratorial exams are valid to complement the diagnosis of the nutritional state in a quick and practical manner. |
| PubMedID- 22523693 | These pleiotropic and highly variable functions go some way towards explaining the miscellany of associations that have been detected for vdr polymorphisms, among others with the occurrence of hepatocellular carcinoma (hcc) in patients with liver cirrhosis, particularly in patients with an alcoholic etiology . |
| PubMedID- 23320019 | Same observations have been reported after sorafenib treatment in mouse tumor models and in the peripheral blood of mrcc patients and hepatocellular carcinoma patients with liver cirrhosis . |
| PubMedID- 19345541 | Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. |
| PubMedID- 26331402 | Is there a survival benefit in interventional radiology for hepatocellular carcinoma in patients with child-pugh c liver cirrhosis. |
| PubMedID- 22028976 | In hepatocellular carcinoma, all patients with liver cirrhosis or chronic hepatitis b virus infection are at risk. |
| PubMedID- 20304209 | The best treatment for hepatocellular carcinoma (hcc) associated with liver cirrhosis is liver transplantation and the best results are obtained when the tumors fulfill the milan criteria. |
| PubMedID- 23918576 | Patients were excluded for one of the following: 1) ascites due to liver cirrhosis with or without hepatocellular carcinoma, chronic renal failure, heart failure, or any malignancy other than epithelial ovarian cancer, 2) pregnancy, 3) previous history of malignancy or current evidence of any malignancy other than epithelial ovarian cancer, 4) recurred epithelial ovarian cancer or benign ovarian tumor, or 5) previous history of abdominal surgery. |
| PubMedID- 22666283 | Sorafenib prevents escape from host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma. |
| PubMedID- 23691139 | This appears to happen during hepatocellular carcinoma (hcc) development in patients with liver cirrhosis, however, the accompanying transcriptional changes are virtually unknown. |
| PubMedID- 20857114 | Purpose: we have previously shown that continuous intra-arterial combination chemotherapy (iacc) might be more effective for advanced hepatocellular carcinoma (ahcc) in patients with hcv-related liver cirrhosis (c-lc) or alcoholic liver cirrhosis (a-lc) than in patients with hbv-related lc (b-lc). |
| PubMedID- 25465278 | It remains to be determined to what extent hcv clearance will alter liver function and the risk for hepatocellular carcinoma in patients with liver cirrhosis. |
| PubMedID- 25138286 | Purpose: the aim of this retrospective cohort study was to clarify the effect of a branched-chain amino acids (bcaa) on the liver function and the prognosis of child-pugh class (c-p) a and b liver cirrhosis (lc) patients with advanced hepatocellular carcinoma (ahcc) undergoing hepatic arterial infusion chemotherapy (haic). |
| PubMedID- 23316254 | Demonstrate that sorafenib-induced th1 dominance can prevent the escape of tumor cells from the host immune system in liver cirrhosis (lc) patients with advanced hepatocellular carcinoma (ahcc). |
| PubMedID- 24223741 | Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis. |
| PubMedID- 23146511 | Introduction: the coexistence of liver cirrhosis with hepatocellular carcinoma (hcc) and colon cancer (ca), which is a rare clinical condition, was treated in a liver transplant recipient. |
| PubMedID- 25091611 | hepatocellular carcinoma (hcc)-closely associated with liver cirrhosis and, in fact, the main cause of death in patients with such disease-is now recognized as one of the most-prevalent and lethal neoplasms worldwide. |
| PubMedID- 23708326 | Branched-chain amino acids (bcaas) reportedly inhibit the incidence of hepatocellular carcinoma (hcc) in patients with liver cirrhosis and obesity that is frequently associated with insulin resistance (ir). |
| PubMedID- 24746085 | Objective: to explore the surveillance and diagnostic values of ultrasound (us), computed tomography (ct) and magnetic resonance imaging (mri) follow-ups in malignant transformation of cirrhotic nodules so as to improve the diagnostic accuracy of early hepatocellular carcinoma (hcc) with liver cirrhosis. |
| PubMedID- 21663667 | About 75% of patients achieve no therapeutic benefit from the present combination therapy with pegylated interferon α (peg-ifn-α) and ribavirin mainly depending upon hcv genotype, whereas in 40-60% patients chronic infection is mainly associated with liver cirrhosis and steatosis leading to hepatocellular carcinoma (hcc) . |
| PubMedID- 22606287 | Ald-associated disorders include fatty liver, inflammation, and hepatocellular carcinoma in patients with liver cirrhosis . |
| PubMedID- 20372847 | Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis. |
| PubMedID- 22882828 | Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis. |
| PubMedID- 24229043 | A 69-year-old woman, who underwent cadaveric liver transplantation for non-b, non-c liver cirrhosis with hepatocellular carcinoma in april 2009, was admitted to our hospital because of graft dysfunction. |
| PubMedID- 26116049 | Risk factors for incisional hernia after hepatic resection for hepatocellular carcinoma in patients with liver cirrhosis. |
| PubMedID- 20012230 | Methods: in this study, we enrolled 20 patients having liver cirrhosis with hepatocellular carcinoma and randomly assigned them into two groups to receive autologous stem cells or placebo. |
| PubMedID- 25513088 | As hepatocellular carcinoma is often associated with liver cirrhosis, patients are at risk for postoperative liver failure. |
| PubMedID- 21377941 | Conclusions: contrast enhanced ultrasound has a high diagnostic value and reproducibility for non-invasive grading of hypervascular hepatocellular carcinoma >1cm in patients with liver cirrhosis. |
| PubMedID- 21210013 | Aim: the ultrasonographic (us) detection of hepatocellular carcinoma (hcc) in patients with liver cirrhosis is based on the visualization of focal lesions. |
| PubMedID- 26444667 | Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma. |
| PubMedID- 22776279 | Their perioperative course was favorable and comparable to that of other hepatocellular carcinoma patients with mild-moderate liver cirrhosis. |
| PubMedID- 24223226 | Furthermore, bcaa supplementation has been suggested to prevent the incidence of hepatocellular carcinoma in patients with liver cirrhosis . |
| PubMedID- 26166077 | Magnetic resonance spectroscopy was used as a means of predicting the probability of developing hepatocellular carcinoma (hcc) in patients with liver cirrhosis secondary to chronic hepatitis b.this study included 20 healthy volunteers, 20 patients with liver cirrhosis secondary to chronic hepatitis b (cirrhosis group), and 20 patients with small hcc secondary to cirrhosis liver parenchyma (hcc group). |
| PubMedID- 22483505 | The patient was a 62-year-old man, who suffered decompensated liver cirrhosis with hepatocellular carcinoma. |
| PubMedID- 20087783 | Background: the antiangiogenic drug sorafenib has been shown to be an effective treatment for hepatocellular carcinoma (hcc) in patients with liver cirrhosis. |
| PubMedID- 23904843 | The greatest advantage of pure laparoscopic hepatectomy for hepatocellular carcinoma with concomitant liver cirrhosis is that postoperative ascites retention is minimal, meaning that there is little risk of water-electrolyte imbalance associated with ascites retention or hypoproteinemia. |
| PubMedID- 24949326 | We recently experienced a case of ldlt for hepatocellular carcinoma combined with liver cirrhosis secondary to hepatitis b virus and hepatitis c virus infection. |
| PubMedID- 23392977 | Impact of laparoscopic liver resection for hepatocellular carcinoma with f4-liver cirrhosis. |
| PubMedID- 25852766 | Oldenlandia diffusa promotes antiproliferative and apoptotic effects in a rat hepatocellular carcinoma with liver cirrhosis. |
| PubMedID- 22254115 | Chronic ethanol consumption causes changes in the liver, including fatty liver, inflammation and cirrhosis , and is an established risk factor for the development of hepatocellular carcinoma in patients with liver cirrhosis . |
| PubMedID- 25891119 | The present study examined the prognostic ability of our proposed performance status combined japan integrated staging (ps-jis) system in hepatocellular carcinoma (hcc) patients with liver cirrhosis (lc) comparing with other four prognostic systems including original jis system, the barcelona clinic liver cancer classification system, tnm classification system and the cancer of the liver italian program (clip) scoring system. |
Page: 1 2